Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jun 17
Love0

Hyperpigmented Macules and Patches on the Face: Exogenous Ochronosis or Lichen Planus Pigmentosus?

By Chuck Lin No Comments
INTRODUCTIONExogenous ochronosis (EO) is a common skin condition that presents as asymptomatic hyperpigmentation after using products containing hydroquinone. Other causative agents include resorcinol, phenol, mercury, picric acid, and antimalarials such…
Read More
Jun 17
Love0

Examining Racial Diversity in Hyperpigmentation and Post-Inflammatory Hyperpigmentation Clinical Trials in the United States

By Chuck Lin No Comments
To the Editor:  Dyspigmentation, specifically hyperpigmentation or post-inflammatory hyperpigmentation (PIH), disproportionately affects those with skin of color. Studies show that dyschromias, including PIH, are one of the most common presenting…
Read More
Jun 17
Love0

Sunscreen Use for Photoprotection in Skin of Color: A Literature Review

By Chuck Lin No Comments
INTRODUCTIONMisperceptions around the use of sunscreen for photoprotection for individuals with darker skin types result in the underutilization of this effective means to reduce the sequelae of sun exposure. The…
Read More
Jun 12
Love0

Efficacy, Safety, Satisfaction, Adherence to Treatment With Nano-Formulated Cysteamine Tranexamic Acid Cream to Treat Melasma

By Chuck Lin No Comments
INTRODUCTIONMelasma is an acquired pigmentary condition primarily affecting sun-exposed skin. The pathogenesis of melasma remains unknown, encompassing genetic factors, sun exposure, hormonal contraceptives, photosensitizing drugs, skin inflammation, and stress.1  The…
Read More
Jun 12
Love0

DermTok: Who’s Talking Sun? A Cross-Sectional Analysis of Sun Protection Content on TikTok

By Chuck Lin No Comments
INTRODUCTIONTikTok provides a platform for users to create and watch short videos covering diverse topics, including the field of dermatology. With a user base of over one billion, TikTok has…
Read More
Jun 11
Love0

Assessing the Impact of Visual and Audio Media on Sunscreen Use Among People of Color: Pre- and Post-Survey

By Chuck Lin No Comments
INTRODUCTIONIt is well understood that people of color (POC) are at lower risk for developing melanoma compared to their white counterparts. However, skin cancer tends to be diagnosed at a…
Read More
Jun 10
Love0

Mycosis Fungoides Palmaris et Plantaris Mimicking “Dyshidrotic Eczema”: A Case Report

By Chuck Lin No Comments
INTRODUCTIONThe resemblance of mycosis fungoides (MF) to prevalent skin disorders such as atopic dermatitis presents a diagnostic challenge for dermatologists. Histopathologic criteria may demonstrate a lichenoid infiltrate mixed with coarse…
Read More
May 30
Love0

An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color

By Chuck Lin No Comments
BACKGROUNDAcne vulgaris is a common skin disease characterized by inflammatory papules, pustules, and comedones that is prevalent in men and women of color. Acne is the most common dermatologic diagnosis…
Read More
May 30
Love0

Anifrolumab for the Dermatologist

By Chuck Lin No Comments
INTRODUCTION The type 1 interferon (IFN) signaling pathway is considered a key player in the pathogenesis of systemic lupus erythematosus.1,2 Elevated serum levels of type 1 IFNs and IFN-inducible gene…
Read More
May 30
Love0

Treatment of Bullous Pemphigoid With Dupilumab: A Case Series of 30 Patients

By Chuck Lin No Comments
INTRODUCTIONBullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease, propagated by autoantibodies against BP antigen 230 (BPAG1) and BP antigen 180 (BPAG2).1 Classically, it presents with intensely pruritic…
Read More
May 29
Love0

Topical Clindamycin in the Management of Acne Vulgaris: Current Perspectives and Recent Therapeutic Advances

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris (AV) is a common skin disorder, affecting almost 100% of adolescents at some point1 and persisting in over 60% and 40% of individuals in their 20s and 30s,…
Read More
May 29
Love0

Investigating the Relationship Between Acne and Vasodilatory Medications in a Hospital-Wide Adult Population

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris is a prevalent chronic dermatological condition characterized by obstruction and inflammation of pilosebaceous units.1,2 Acne presents clinically as inflammatory papules, pustules, nodules, and/or cysts.3 The pathogenesis involves a…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors May 23, 2025
  • A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis May 22, 2025
  • Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study May 21, 2025
  • JDD in the News: Upadacitinib’s Potential Cardiovascular Effects  May 21, 2025
  • Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares May 20, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search